Skip to content
The Great News – Lifestyle
Home
Sample Page
Author:
Spago Nanomedical
Spago Nanomedical Resolves on a Rights Issue of Approximately SEK 16 Million
May 22, 2026
Spago Nanomedical Publishes the Annual Report for 2025
May 19, 2026
Spago Nanomedical Presents Tumorad(R) Clinical Data at the International ANZSNM 2026 Conference
May 18, 2026
Notice To Annual General Meeting of Spago Nanomedical AB (PUBL)
May 11, 2026
Spago Nanomedical Interim Report January-March 2026
May 7, 2026
Spago Nanomedical’s Phase I/IIa study Tumorad-01 Meets a Primary Endpoint and Provides Further Visible Tumor Uptake
May 6, 2026
Spago Nanomedical Continues Recruitment in The Phase I/IIa Tumorad-01 Study Following Positive DMC Recommendation
March 17, 2026
Spago Nanomedical Strengthens CMC and Supply Capabilities to Support Next Phase of Tumorad Development
March 10, 2026